Results for tag: "Glutamate Receptor"

The Glutamate Receptor market is a subset of the Central Nervous System Drugs market. Glutamate Receptors are proteins found in the brain and are responsible for the majority of excitatory neurotransmission. They are involved in a variety of neurological processes, including learning, memory, and cognition. As such, they are a target for drug development, with the aim of treating neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. The Glutamate Receptor market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms vying for market share. Companies in the market include Merck, Pfizer, Novartis, Eli Lilly, and AstraZeneca. Additionally, there are a number of smaller companies, such as Neurocrine Biosciences, that are developing drugs targeting Glutamate Receptors. Show Less Read more